Duality Advisers’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,400
Closed -$380K 91
2024
Q1
$380K Buy
+3,400
New +$367K 0.04% 481
2023
Q3
Sell
-5,163
Closed -$488K 567
2023
Q2
$488K Buy
+5,163
New +$436K 0.06% 394
2023
Q1
Sell
-8,290
Closed -$637K 581
2022
Q4
$637K Buy
+8,290
New +$630K 0.07% 399
2022
Q1
Sell
-10,510
Closed -$541K 647
2021
Q4
$541K Sell
10,510
-47,407
-82% -$2.33M 0.06% 390
2021
Q3
$2.87M Buy
+57,917
New +$3.14M 0.22% 188
2020
Q4
Sell
-5,500
Closed -$258K 567
2020
Q3
$258K Buy
+5,500
New +$282K 0.02% 539
2020
Q1
Sell
-18,354
Closed -$928K 47
2019
Q4
$928K Buy
18,354
+6,874
+60% +$355K 0.06% 281
2019
Q3
$542K Buy
+11,480
New +$524K 0.03% 291
2019
Q2
Sell
-54,050
Closed -$2.6M 234
2019
Q1
$2.6M Buy
+54,050
New +$2.71M 0.15% 151

Other funds holding CAH

Duality Advisers's CAH Position: Q2 2024 in Review

Duality Advisers sold out of Cardinal Health (CAH) in Q2 2024, closing a stake of 3,400 shares — an estimated $380K sold.

Duality Advisers first reported a position in CAH in Q1 2019 and held it in 9 quarters. The position peaked at $2.87M in Q3 2021. 1,009 funds tracked by Wall St. Rank hold CAH as of Q2 2024.

  • Duality Advisers reported no remaining Cardinal Health position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 3,400 Cardinal Health shares in Q2 2024, an estimated $380K.
  • Duality Advisers first reported a position in Cardinal Health in Q1 2019 and held it in 9 quarters.
  • Duality Advisers's Cardinal Health position peaked at $2.87M in Q3 2021.
  • 1,009 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.